AmyPore develops a chimeric peptide generated through a strategy of artificial intelligence applied to the molecular neuroscience designed for blocking the formation of neurotoxic structures responsible for Alzheimer's / Parkinson's diseases.
Automatic translation

Technologies

  • AI
  • BIOENGINEERING

Activity area

  • HEALTHTECH
  • PHARMATECH
  • NEUROTECH
  • BIOTECH

Maturity stage

  • Mature

Key information

Year of creation

2018

Workforce

< 10

Maturity stage

Mature